The 2024 US task force update lowered the routine mammography start to forty, recommending screening every two years for women forty to seventy four at average risk. Known mutation carriers and strong family histories follow separate high risk protocols that begin earlier and add MRI. Enter age and risk level to see which of the four guidance categories applies.
Your visual report appears here
Fill in the form and press Calculate. You will get your number, an interpretation chip, and a personalized chart pack drawn instantly in your browser.
- Risk spectrum with your position marked
- Reference ranges from the original publication
- Shareable link, nothing stored
Scientific references
Breast screening guidance shifted meaningfully in 2024 when the US Preventive Services Task Force dropped the starting age from fifty to forty, following rising incidence in younger women and modeling that showed biennial mammography from forty saves more lives at acceptable harm. The recommendation now covers women forty through seventy four every two years.
The Four Categories
Under forty at average risk, routine screening is not recommended, though any lump or symptom warrants immediate evaluation regardless of age. Forty to seventy four is the core biennial mammography band. Past seventy four evidence thins, and the decision individualizes around health and life expectancy. The fourth category stands apart, women with BRCA mutations, prior chest radiation or strong family history follow specialist protocols, typically starting at thirty with annual MRI plus mammography.
Why Every Two Years
Annual screening catches slightly more cancers but doubles false alarms, callbacks and biopsies that find nothing. Modeling consistently shows biennial screening preserves most of the benefit with about half the harms, the balance the task force favored. Some bodies, including the American Cancer Society, still offer annual options in the forties and fifties, so discussing interval preference with your doctor is legitimate.
Dense Breasts Change the Picture
Half of screened women have dense tissue that both hides tumors on mammography and independently raises risk. Many jurisdictions now mandate density notification, and supplemental ultrasound or MRI may follow, though evidence for universal supplemental screening is still maturing.
Whatever the category, screening works only when attended. The majority of breast cancer deaths occur in women not up to date with mammography, which is the cheapest statistic in oncology to change.